Work

Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs

Year: 2005

Type: article

Source: Leukemia

DOI: 10.1038/sj.leu.2403776

Authors: S Kumar, N Raje, T Hideshima, K Ishitsuka, A Roccaro, N Shiraishi, M Hamasaki, H Yasui, N C Munshi, P Richardson, W D Figg, K C Anderson

Institutions: Mayo Clinic, Harvard University, VA Boston Healthcare System, Dana-Farber Cancer Institute, National Institutes of Health, National Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: G1692820905, G2039067399, G3363796603, Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

OpenAlex ID: W1968234852

FWCI: 2.675

Cites: 21

Cited by: 39

Related to: 10